Tuberculosis
What's New
Last Posted: Mar 14, 2019
- Large genomics datasets shed light on the evolution of the Mycobacterium tuberculosis complex.
Chiner-Oms Álvaro et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2019 Feb - Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries.
Andrés Marta et al. PloS one 2019 (3) e0210080 - Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis .
Omar Shaheed V et al. African journal of laboratory medicine 2019 (1) 801 - A systematic review of biomarkers to detect active tuberculosis.
MacLean Emily et al. Nature microbiology 2019 Feb - Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.
Zürcher Kathrin et al. The Lancet. Infectious diseases 2019 Feb - Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
Arandjelovic Irena et al. Emerging infectious diseases 2019 Mar (3) 555-558 - Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
Genestet Charlotte et al. Emerging infectious diseases 2019 Mar (3) 589-592 - Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
Naidoo Anushka et al. Pharmacogenomics 2019 Feb - Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi Noura M et al. BMC infectious diseases 2019 Jan (1) 3 - Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis .
Gygli Sebastian M et al. Antimicrobial agents and chemotherapy 2019 Feb
.png)
No hay comentarios:
Publicar un comentario